Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
June 11, 2025
Tags
Healthy Returns
Social issues
Health & Science
From
CNBC.com News
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
May 21, 2025
Tags
Social issues
Cigna Corp
CVS Health Corp
From
CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
May 19, 2025
Tags
Health care industry
Companies
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
May 16, 2025
Tags
Pharmaceuticals
Europe News
Novo Nordisk A/S
From
CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
May 15, 2025
Tags
Roche Holding AG
Novo Nordisk A/S
Europe: Top News And Analysis
From
CNBC.com News
Why Americans pay so much more for prescription drugs
May 14, 2025
Tags
LILLY DRN
Biotechnology
Politics
From
CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
May 07, 2025
Tags
CVS Health Corp
Healthy Returns
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
May 07, 2025
Tags
AstraZeneca PLC
Business News
Roche Holding AG
From
CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
May 06, 2025
Tags
Hims & Hers Health Inc
Make It / Money
Make It
From
CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
May 05, 2025
Tags
Hims & Hers Health Inc
Health & Science
Breaking News: Technology
From
CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
May 02, 2025
Tags
Investment strategy
Cloudflare Inc
Markets
From
CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
May 02, 2025
Tags
Mergers
Pfizer Inc
Amgen Inc
From
CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
May 01, 2025
Tags
Companies
Health care industry
CVS Health Corp
From
CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
April 29, 2025
Tags
Health care industry
Companies
Hims & Hers Health Inc
From
CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
April 25, 2025
Tags
Health care industry
Social issues
Hims & Hers Health Inc
From
CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
April 22, 2025
Tags
Centene Corp
Social issues
Pfizer Inc
From
CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
April 22, 2025
Tickers
OIL
Tags
Stellantis NV
Autos
Airlines
From
CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
April 17, 2025
Tags
Viking Therapeutics Inc
Companies
AstraZeneca PLC
From
CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
April 14, 2025
Tags
UBS Group AG
World Markets
Market Outlook
From
CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
April 14, 2025
Tags
Pfizer Inc
Health care industry
Companies
From
CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
April 10, 2025
Tags
Politics
Europe Markets
Luxury
From
CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
April 04, 2025
Tags
Companies
Social issues
Health care industry
From
CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
April 03, 2025
Tags
Europe Economy
Kering SA
AstraZeneca PLC
From
CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
April 03, 2025
Tags
Biotechnology
Trade
Bavarian Nordic A/S
From
CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
March 29, 2025
Tags
Breaking News: Business
Business News
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
March 28, 2025
Tags
Biotechnology
Pharmaceuticals
LILLY DRN
From
CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
March 27, 2025
Tags
Biotechnology
Novo Nordisk A/S
LILLY DRN
From
CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
March 26, 2025
Tags
Market Outlook
Markets
Europe Markets
From
CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
March 25, 2025
Tags
Tesla Inc
Markets
Market Outlook
From
CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
March 25, 2025
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health care industry
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.